查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1564996

幽门螺旋桿菌诊断的全球市场

Helicobacter Pylori Diagnostics
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 158 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球幽门螺旋桿菌诊断市场预计将达到 9.641 亿美元

幽门螺旋桿菌诊断的全球市场预计 2023 年为 6.955 亿美元，预计到 2030 年将达到 9.641 亿美元，2023-2030 年分析期间复合年增长率为 4.8%。医院终端用途是本报告分析的细分市场之一，预计复合年增长率为 4.8%，到分析期结束时将达到 4.369 亿美元。在分析期间，诊断中心最终用途细分市场的复合年增长率预计为 5.1%。

美国市场预计将达到1.849亿美元，中国预计复合年增长率为7.2%。

预计 2023 年美国幽门螺旋桿菌诊断市场规模将达 1.849 亿美元。中国作为世界第二大经济体，预计到 2030 年市场规模将达到 2.1 亿美元，2023-2030 年分析期间复合年增长率为 7.2%。其他值得注意的区域市场包括日本和加拿大，预计在分析期间复合年增长率分别为 2.6% 和 4.4%。在欧洲，德国的复合年增长率预计为 2.8%。

全球幽门螺旋桿菌诊断市场 - 主要趋势和驱动因素总结

幽门螺旋桿菌诊断药物对胃健康至关重要吗？

幽门螺旋桿菌（H. pylori）诊断试剂在胃肠道健康管理中变得越来越重要，但为什么诊断这种细菌如此重要？幽门螺旋桿菌是一种常见于胃壁的细菌，也是造成多种胃肠道疾病的主要原因，包括胃炎、消化性溃疡，在某些情况下甚至是胃癌。由于幽门螺旋桿菌可以在胃部严酷的酸性环境中生存，因此如果不进行治疗，感染可能会持续数年，导致慢性消化系统疾病和长期健康併发症。早期准确的检测对于防止这些症状的进展至关重要。

幽门螺旋桿菌病菌感染的诊断非常重要。这是因为幽门螺旋桿菌病菌感染的症状往往与其他胃肠道疾病相似，如果不进行具体测试很难识别。腹痛、腹胀、噁心和消化不良等症状是许多消化系统疾病的通用，因此准确的诊断有助于区分幽门螺旋桿菌病菌感染与其他原因。检测幽门螺旋桿菌的方法有很多种，从血液检查、粪便检验和呼吸检测等非侵入性方法到内视镜检查和切片检查等侵入性方法。每次检查的准确性根据具体情况而有所不同，但早期发现是预防严重併发症的关键。随着人们越来越认识到幽门螺旋桿菌与严重胃肠道疾病之间的关联，准确的诊断对于有效的治疗和管理至关重要。

技术如何改善幽门螺旋桿菌的诊断？

科技的进步大大提高了幽门螺旋桿菌诊断的准确性、速度和便利性，提供了广泛的选择，以满足不同的临床需求。最重要的创新之一是尿素呼气测试，它成为检测幽门螺旋桿菌病菌感染最广泛使用的非侵入性方法。此测试透过测量患者摄取尿素溶液后呼吸中的碳同位素来进行。当幽门螺旋桿菌存在时，细菌会分解尿素并释放二氧化碳，可以在您的呼吸中检测到二氧化碳。这种方法提供了高度准确的结果，对于确认治疗前后的感染特别有用，并且是更具侵入性测试的可靠替代方案。

另一个重大进展是粪便抗原检测，可检测患者粪便检体中的幽门螺旋桿菌蛋白。现代粪便抗原检测灵敏且特异性，为诊断活动性性行为感染提供了方便、非侵入性的选择。这些测试在无法进行内视镜检查和呼吸检测的领域特别有用，并且由于其经济性和可及性而越来越多地在临床环境中使用。

侵入性检测方法，例如切片检查活检，诊断准确性也在提高。切片检查技术和分子检测的进步使得检测幽门螺旋桿菌的抗生素抗药性成为可能，指南更有效的治疗策略。 PCR（聚合酵素链锁反应）等分子诊断方法可以检测出使幽门螺旋桿菌对常用抗生素产生抗药性的特定基因，从而解决因抗药性菌株而导致治疗失败的挑战。这些技术突破使得幽门螺旋桿菌诊断更有效，可以更早、更准确地检测并制定更有针对性的治疗计划。

为什么幽门螺旋桿菌诊断药物对公共卫生至关重要？

幽门螺旋桿菌的诊断对于公共卫生至关重要，因为幽门螺旋桿菌广泛流行并与严重的胃肠道疾病有关。据估计，世界上一半以上的人口都感染幽门螺旋桿菌，但许多人仍然无症状。然而，如果出现症状，可能会导致严重后果，包括慢性胃炎、消化性溃疡，严重时甚至会导致胃癌。世界卫生组织 (WHO) 将幽门螺旋桿菌列为第一类致癌性，因为它与胃癌密切相关，早期检测对于降低这种致命疾病的发生率至关重要。

定期检测幽门螺旋桿菌对于胃肠道疾病高风险族群尤其重要，例如幽门螺旋桿菌病菌感染率高或获得医疗保健机会有限的地区。幽门螺旋桿菌病菌感染的早期诊断和治疗可以预防消化性溃疡的发展，显着降低胃癌的风险，并改善长期健康结果。这对于医疗资源有限的国家尤其重要，因为胃癌是癌症相关死亡的主要原因之一。

在临床实践中，幽门螺旋桿菌的诊断对于治疗经常被误认为其他原因的复发性胃肠道症状至关重要。患有慢性消化不良、胃炎和溃疡的患者通常只接受症状治疗，而没有解决潜在的细菌感染。如果没有正确的诊断，这些患者可能会继续出现反覆出现的症状或随着时间的推移而出现更严重的併发症。准确的检测有助于临床医生根除感染并提供有针对性的治疗以防止復发，改善患者的治疗效果并降低医疗成本。随着人们越来越认识到幽门螺旋桿菌在胃病中的作用，诊断正在成为旨在减轻全球胃病负担的公共卫生倡议的基石。

推动幽门螺旋桿菌诊断市场成长的因素有哪些？

幽门螺旋桿菌诊断市场的成长是由意识的提高、技术的进步以及对胃肠道疾病有效管理的需求不断增长共同推动的。主要因素之一是人们越来越认识到幽门螺旋桿菌病菌感染与胃癌和消化性溃疡等严重健康问题之间的关联。随着越来越多的医疗保健专业人员和公共卫生组织强调早期检测和治疗的重要性，对可靠且易于使用的诊断工具的需求正在迅速增加。在幽门螺旋桿菌病菌感染率高的国家尤其如此，筛检和早期治疗可以显着降低胃癌的发生率。

技术进步也是推动市场成长的主要因素。非侵入性尿素呼气测试和高精度粪便抗原测试等创新使幽门螺旋桿菌诊断更加容易和方便，使医疗保健专业人员无需进行侵入性操作筛检和诊断感染。这些进步使患者更容易接受门诊和家用检测，扩大了诊断服务的范围，并增加了早期发现的可能性。此外，PCR检测等分子诊断方法的发展使得能够检测出抗生素抗药性幽门螺旋桿菌，有助于解决日益严重的抗治疗性问题并提高根除治疗的成功率。

抗药性幽门螺旋桿菌的增加也推动了对更先进诊断方法的需求。由于抗生素抗药性持续使治疗变得复杂，因此在开始治疗之前进行能够检测抗药性菌株的测试至关重要。透过识别抗药性模式，这些诊断可以帮助医生开出最有效的抗生素，减少治疗失败的机会并防止抗药性细菌的传播。随着医疗保健系统寻求改善治疗结果，同时对抗抗生素抗药性，这种向精准医疗的转变正在推动诊断市场的成长。

最后，人们对预防医学的兴趣日益浓厚，推动了对幽门螺旋桿菌诊断的需求。许多医疗机构已经实施了针对高风险族群的筛检计划，以便在病菌感染导致更严重的疾病之前检测和治疗它。这种预防方法不仅可以改善患者的治疗效果，还可以降低与晚期胃病治疗相关的长期医疗费用。随着全球医疗保健趋势继续优先考虑早期检测和精准治疗，对准确且易于使用的幽门螺旋桿菌诊断的需求不断增加，使其成为医疗诊断市场的关键成长领域。

受访企业范例（共12家）

  • Abbott Laboratories
  • Bio-Rad Laboratories, Inc.
  • Cardinal Health, Inc.
  • DiaSorin SpA
  • Exalenz Bioscience Ltd.
  • F. Hoffmann-La Roche AG
  • Halyard Health, Inc.
  • Meridian Bioscience, Inc.
  • Quidel Corporation
  • Thermo Fisher Scientific, Inc.

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 比赛

简介目录
Product Code: MCP12332

Global Helicobacter Pylori Diagnostics Market to Reach US$964.1 Million by 2030

The global market for Helicobacter Pylori Diagnostics estimated at US$695.5 Million in the year 2023, is expected to reach US$964.1 Million by 2030, growing at a CAGR of 4.8% over the analysis period 2023-2030. Hospitals End-Use, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$436.9 Million by the end of the analysis period. Growth in the Diagnostics Centers End-Use segment is estimated at 5.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$184.9 Million While China is Forecast to Grow at 7.2% CAGR

The Helicobacter Pylori Diagnostics market in the U.S. is estimated at US$184.9 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$210.0 Million by the year 2030 trailing a CAGR of 7.2% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.6% and 4.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.8% CAGR.

Global Helicobacter Pylori Diagnostics Market - Key Trends and Drivers Summarized

Is Helicobacter Pylori Diagnostics Crucial for Stomach Health?

Helicobacter pylori (H. pylori) diagnostics are becoming increasingly important in the management of gastrointestinal health, but what makes diagnosing this bacteria so critical? H. pylori is a type of bacteria commonly found in the stomach lining and is the leading cause of various gastrointestinal disorders, including gastritis, peptic ulcers, and, in some cases, gastric cancer. Because of its ability to survive in the harsh acidic environment of the stomach, H. pylori infections can persist for years without treatment, leading to chronic digestive issues and long-term health complications. Early and accurate detection is essential to preventing the progression of these conditions.

Diagnosing H. pylori infections is crucial because symptoms can often mimic other gastrointestinal problems, making it difficult to identify without specific tests. Symptoms like abdominal pain, bloating, nausea, and indigestion are common in many digestive disorders, so accurate diagnostics help differentiate H. pylori infections from other causes. Tests for H. pylori range from non-invasive methods, such as blood tests, stool tests, and breath tests, to invasive procedures like endoscopy and biopsy. Each test offers varying degrees of accuracy, depending on the situation, but early detection is key in preventing severe complications. As awareness of H. pylori’s link to serious gastrointestinal diseases grows, the demand for precise diagnostics is becoming more critical to effective treatment and management.

How Has Technology Improved Helicobacter Pylori Diagnostics?

Technological advancements have significantly improved the accuracy, speed, and ease of Helicobacter pylori diagnostics, offering a range of options tailored to different clinical needs. One of the most significant innovations is the urea breath test, which has become one of the most widely used non-invasive methods for detecting H. pylori infections. This test works by measuring carbon isotopes in the breath after a patient ingests a urea solution. If H. pylori is present, the bacteria will break down the urea, releasing carbon dioxide that can be detected in the breath. This method provides highly accurate results and is particularly useful for confirming infection before and after treatment, offering a reliable alternative to more invasive testing.

Another major advancement is in stool antigen testing, which detects H. pylori proteins in a patient's stool sample. Modern stool antigen tests are highly sensitive and specific, offering a convenient, non-invasive option for diagnosing active infections. These tests are particularly valuable in areas where endoscopy or breath tests may not be readily available, and they are increasingly used in clinical settings due to their affordability and accessibility.

Invasive testing methods, such as endoscopy with biopsy, have also seen improvements in diagnostic accuracy. Advances in biopsy techniques and molecular testing now allow for the detection of antibiotic resistance in H. pylori strains, guiding more effective treatment strategies. Molecular diagnostics, such as PCR (polymerase chain reaction), can detect specific genes in H. pylori that confer resistance to commonly used antibiotics, helping to address the rising challenge of treatment failure due to drug-resistant strains. These technological breakthroughs have made H. pylori diagnostics more effective, enabling earlier and more precise detection and better-targeted treatment plans.

Why Are Helicobacter Pylori Diagnostics Essential for Public Health?

H. pylori diagnostics are essential for public health due to the bacteria’s widespread prevalence and its role in severe gastrointestinal diseases. It is estimated that over half of the global population is infected with H. pylori, though many remain asymptomatic. However, for those who do develop symptoms, the consequences can be serious, including chronic gastritis, peptic ulcers, and, in extreme cases, gastric cancer. The World Health Organization (WHO) has classified H. pylori as a Group 1 carcinogen due to its strong link to stomach cancer, making early detection a priority for reducing the incidence of this deadly disease.

Routine testing for H. pylori is particularly important in populations at high risk for gastrointestinal disorders, including regions where H. pylori infection rates are high or where access to healthcare is limited. Diagnosing and treating H. pylori infections early can prevent the development of peptic ulcers and significantly reduce the risk of stomach cancer, improving long-term health outcomes. This is especially important in countries with limited resources, where gastric cancer remains one of the leading causes of cancer-related deaths.

In clinical practice, diagnosing H. pylori is crucial for managing recurrent gastrointestinal symptoms that are often misattributed to other causes. Patients with chronic indigestion, gastritis, or ulcers are often treated symptomatically without addressing the underlying bacterial infection. Without proper diagnostics, these patients may continue to suffer from recurring symptoms or develop more serious complications over time. Accurate testing helps clinicians provide targeted treatments that eradicate the infection and prevent relapses, leading to better patient outcomes and reduced healthcare costs. As awareness of H. pylori's role in gastric diseases grows, diagnostics are becoming a cornerstone of public health initiatives aimed at reducing the global burden of stomach disorders.

What Factors Are Driving the Growth of the Helicobacter Pylori Diagnostics Market?

The growth in the Helicobacter pylori diagnostics market is driven by a combination of rising awareness, technological advancements, and increasing demand for effective management of gastrointestinal disorders. One of the primary drivers is the growing recognition of the link between H. pylori infection and serious health issues such as gastric cancer and peptic ulcers. As more healthcare professionals and public health organizations emphasize the importance of early detection and treatment, the demand for reliable, accessible diagnostic tools has surged. This is particularly true in countries with high H. pylori infection rates, where screening and early treatment can significantly reduce the incidence of gastric cancer.

Technological advancements are another major factor propelling market growth. Innovations such as non-invasive urea breath tests and highly accurate stool antigen tests have made H. pylori diagnostics more accessible and convenient, allowing healthcare providers to screen and diagnose infections without the need for invasive procedures. These advancements have made it easier for patients to be tested in outpatient or even home settings, broadening the reach of diagnostic services and increasing the likelihood of early detection. In addition, the development of molecular diagnostics, such as PCR tests, allows for the detection of antibiotic-resistant H. pylori strains, helping to combat the growing problem of treatment resistance and improve the success rates of eradication therapies.

The increasing prevalence of drug-resistant H. pylori strains is also driving demand for more advanced diagnostics. As antibiotic resistance continues to complicate treatment, the need for tests that can detect resistant strains before treatment is initiated has become critical. By identifying resistance patterns, these diagnostics help physicians prescribe the most effective antibiotics, reducing the likelihood of treatment failure and preventing the spread of resistant bacteria. This shift toward precision medicine is driving growth in the diagnostics market as healthcare systems seek to improve treatment outcomes while combating antibiotic resistance.

Lastly, the growing focus on preventive healthcare is pushing the demand for H. pylori diagnostics. Many health systems are adopting screening programs aimed at high-risk populations to detect and treat H. pylori infections before they lead to more severe diseases. This preventive approach not only improves patient outcomes but also reduces the long-term healthcare costs associated with treating advanced gastric diseases. As global healthcare trends continue to prioritize early detection and precision treatment, the demand for accurate and accessible H. pylori diagnostics is set to rise, making it a critical area of growth in the medical diagnostics market.

Select Competitors (Total 12 Featured) -

  • Abbott Laboratories
  • Bio-Rad Laboratories, Inc.
  • Cardinal Health, Inc.
  • DiaSorin SpA
  • Exalenz Bioscience Ltd.
  • F. Hoffmann-La Roche AG
  • Halyard Health, Inc.
  • Meridian Bioscience, Inc.
  • Quidel Corporation
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Helicobacter Pylori Diagnostics - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Helicobacter Pylori Infections Drives Demand for Diagnostic Solutions
    • Growth in Gastrointestinal Disease Screening Expands Addressable Market for H. Pylori Diagnostics
    • Increasing Focus on Early Detection and Treatment of Peptic Ulcers Spurs Adoption of H. Pylori Testing
    • Growth in Use of Urea Breath Tests (UBT) for Non-invasive H. Pylori Detection Drives Adoption
    • Increasing Demand for Point-of-care Testing Solutions Expands Market for H. Pylori Diagnostics
    • Expansion of Diagnostic Laboratories and Healthcare Facilities Boosts Availability of H. Pylori Testing
    • Market Dynamics Driven by Rising Prevalence of Antibiotic-resistant Strains of H. Pylori
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Helicobacter Pylori Diagnostics Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Helicobacter Pylori Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Helicobacter Pylori Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Diagnostics Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Diagnostics Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Diagnostics Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Invasive by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Invasive by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Invasive by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Non-Invasive by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Non-Invasive by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Non-Invasive by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Helicobacter Pylori Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: USA 16-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2014, 2024 & 2030
    • TABLE 23: USA Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: Canada 16-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2014, 2024 & 2030
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • JAPAN
    • Helicobacter Pylori Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: Japan 16-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2014, 2024 & 2030
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • CHINA
    • Helicobacter Pylori Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: China 16-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2014, 2024 & 2030
    • TABLE 41: China Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: China 16-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • EUROPE
    • Helicobacter Pylori Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Helicobacter Pylori Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: Europe 16-Year Perspective for Helicobacter Pylori Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2014, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • FRANCE
    • Helicobacter Pylori Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 53: France Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: France 16-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2014, 2024 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: France 16-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • GERMANY
    • Helicobacter Pylori Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: Germany 16-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2014, 2024 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: Italy 16-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2014, 2024 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Helicobacter Pylori Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 71: UK Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: UK 16-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2014, 2024 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: Spain 16-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2014, 2024 & 2030
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Russia 16-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2014, 2024 & 2030
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Rest of Europe 16-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2014, 2024 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Helicobacter Pylori Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Helicobacter Pylori Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Asia-Pacific 16-Year Perspective for Helicobacter Pylori Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2014, 2024 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Helicobacter Pylori Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: Australia 16-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2014, 2024 & 2030
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • INDIA
    • Helicobacter Pylori Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 110: India Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: India 16-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2014, 2024 & 2030
    • TABLE 113: India Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 115: India 16-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 118: South Korea 16-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2014, 2024 & 2030
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 16-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2014, 2024 & 2030
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Helicobacter Pylori Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Helicobacter Pylori Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 130: Latin America 16-Year Perspective for Helicobacter Pylori Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2014, 2024 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 139: Argentina 16-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2014, 2024 & 2030
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 145: Brazil 16-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2014, 2024 & 2030
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 151: Mexico 16-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2014, 2024 & 2030
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 157: Rest of Latin America 16-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2014, 2024 & 2030
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Helicobacter Pylori Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Helicobacter Pylori Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 163: Middle East 16-Year Perspective for Helicobacter Pylori Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2014, 2024 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 172: Iran 16-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2014, 2024 & 2030
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 178: Israel 16-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2014, 2024 & 2030
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 184: Saudi Arabia 16-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2014, 2024 & 2030
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 190: UAE 16-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2014, 2024 & 2030
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 196: Rest of Middle East 16-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2014, 2024 & 2030
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030
  • AFRICA
    • Helicobacter Pylori Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Helicobacter Pylori Diagnostics by End-Use - Hospitals, Diagnostics Centers and Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 202: Africa 16-Year Perspective for Helicobacter Pylori Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostics Centers and Clinics for the Years 2014, 2024 & 2030
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Helicobacter Pylori Diagnostics by Test Type - Invasive and Non-Invasive Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for Helicobacter Pylori Diagnostics by Test Type - Percentage Breakdown of Value Sales for Invasive and Non-Invasive for the Years 2014, 2024 & 2030

IV. COMPETITION